April 17, 2018 / 8:44 PM / 8 months ago

BRIEF-Endo International Receives Paragraph IV Notification On Vasostrict

April 17 (Reuters) - Endo International PLC:

* ENDO RECEIVES PARAGRAPH IV NOTIFICATION ON VASOSTRICT

* ENDO INTERNATIONAL-LETTER CONTAINS CERTIFICATIONS ALLEGING INVALIDITY,NON-INFRINGEMENT FOR 5 PATENTS CO LISTED IN APPROVED DRUG PRODUCTS FOR VASOSTRICT

* ENDO IS ASSESSING DETAILS OF NOTICE LETTER AND FORMULATING ITS LEGAL STRATEGY

* ENDO INTERNATIONAL - NOTICE LETTER ADVISING THAT EAGLE PHARMACEUTICALS SUBMITTED ANDA TO FDA SEEKING APPROVAL TO MARKET GENERIC VERSION OF VASOSTRICT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below